Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Reneuron Group Plc (EM) RNUGF

Healthcare Biotechnology
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are... see more

Current News (EXPM:RNUGF)

ReNeuron Group (RENE): Differentiating in Exosome Drug Delivery

ACCESS Newswire October 10, 2022

ReNeuron Group (RENE): Extension Trial to Produce Data in Q122

ACCESS Newswire October 11, 2021

Edison Issues Update on ReNeuron Group (RENE)

ACCESS Newswire May 20, 2019

Edison Issues Update on ReNeuron Group (RENE)

ACCESS Newswire May 22, 2018
View More News ››

Opinion & Analysis (EXPM:RNUGF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:RNUGF)

About RENEURON

I'd just like to know if this is faulse as it's a lot of money to lose.. if anyone can help with proof there wasn't a reverse...
Nathan1983 - November 7, 2019

About RENEURON

Me and a mate brought into RENEURON in May 2016 at 1.7p a block of 10000 each now there saying that there was a reverse stock split and...
Nathan1983 - November 7, 2019
View more Bullboard ››

Geekco Technologies Corp.

Geekco Technologies Corp.

Geekco Technologies Corporation, together with its subsidiary, engages in developing and operating mobile applications in ...
View More »

Podcasts